NeoGenomics launches university partnership

FORT MYERS — Cancer-testing laboratory NeoGenomics says it has entered into a research agreement with Robert H. Lurie Comprehensive Cancer Center of Northwestern University and the Northwestern Medicine Developmental Therapeutics Institute.

Terms of the deal were not disclosed, but the Fort Myers-based company says in a statement that the agreement will help expand cancer tests to develop new therapeutics for cancer.

“We believe that collaboration between academia and industry is key for successful innovation and improved patient care,” says Maher Albitar, chief medical officer and director of research and development at NeoGenomics, in a statement.